These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15467767)

  • 1. S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas.
    Smith SL; Gugger M; Hoban P; Ratschiller D; Watson SG; Field JK; Betticher DC; Heighway J
    Br J Cancer; 2004 Oct; 91(8):1515-24. PubMed ID: 15467767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC).
    Strazisar M; Mlakar V; Glavac D
    Cell Mol Biol Lett; 2009; 14(3):442-56. PubMed ID: 19238334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
    Feng G; Xu X; Youssef EM; Lotan R
    Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
    Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.
    Wang BY; Gil J; Kaufman D; Gan L; Kohtz DS; Burstein DE
    Hum Pathol; 2002 Sep; 33(9):921-6. PubMed ID: 12378518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development.
    Shimada A; Kano J; Ishiyama T; Okubo C; Iijima T; Morishita Y; Minami Y; Inadome Y; Shu Y; Sugita S; Takeuchi T; Noguchi M
    Cancer Sci; 2005 Oct; 96(10):668-75. PubMed ID: 16232198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
    Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
    Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer.
    Strazisar M; Rott T; Glavac D
    Lung Cancer; 2009 Mar; 63(3):354-9. PubMed ID: 18656279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
    Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
    J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinicopathological significance of S100 calcium binding protein A2 in lung cancer patients of Chinese Han ethnicity.
    Wang T; Liang Y; Thakur A; Zhang S; Liu F; Khan H; Shi P; Wang N; Chen M; Ren H
    Clin Chim Acta; 2017 Jan; 464():118-122. PubMed ID: 27876462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes.
    Matsubara D; Niki T; Ishikawa S; Goto A; Ohara E; Yokomizo T; Heizmann CW; Aburatani H; Moriyama S; Moriyama H; Nishimura Y; Funata N; Fukayama M
    Cancer Sci; 2005 Dec; 96(12):844-57. PubMed ID: 16367903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
    Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
    J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma.
    Vermylen P; Roufosse C; Burny A; Verhest A; Bosschaerts T; Pastorekova S; Ninane V; Sculier JP
    Eur Respir J; 1999 Oct; 14(4):806-11. PubMed ID: 10573225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
    Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
    J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients.
    Smith AL; Hung J; Walker L; Rogers TE; Vuitch F; Lee E; Gazdar AF
    Br J Cancer; 1996 Jan; 73(2):203-9. PubMed ID: 8546907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer.
    Koyi H; Brandén E; Kasim I; Wilander E
    Anticancer Res; 2018 Jun; 38(6):3341-3346. PubMed ID: 29848682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.
    Leinonen T; Pirinen R; Böhm J; Johansson R; Rinne A; Weber E; Kosma VM
    J Clin Pathol; 2007 May; 60(5):515-9. PubMed ID: 16790691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.